HYUN-JOO PARK: Open Payments
NPI 1497003750 · BAKERSFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,082 in 84 payments from 22 companies in 2025. Trend: 2023 $1,933 · 2024 $2,049 · 2025 $2,082
Food & beverage: $2,048Education: $34
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 13 | $367 |
| Merck Sharp & Dohme LLC | 11 | $290 |
| ABBVIE INC. | 6 | $235 |
| Lilly USA, LLC | 9 | $171 |
| Verona Pharma, Inc. | 6 | $160 |
| GlaxoSmithKline, LLC. | 10 | $144 |
| Phathom Pharmaceuticals, Inc. | 1 | $130 |
| Amgen Inc. | 4 | $92 |
| AstraZeneca Pharmaceuticals LP | 4 | $71 |
| Regeneron Healthcare Solutions, Inc. | 3 | $68 |
Products named: WINREVAIR, JARDIANCE, Ohtuvayre, VOQUEZNA, UBRELVY, VRAYLAR, DUPIXENT, OFEV.
Industry payments across CA — which companies pay providers there.
